Home › Multiple Myeloma › Arkansas
Multiple Myeloma clinical trials in Arkansas
9 studies for Multiple Myeloma are looking for participants at sites in Arkansas.
Cities in Arkansas
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- UAMS, Little Rock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07258511A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- University of Arkansas for Medical Sciences, Little Rock
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04634552A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Highlands Oncology Group, Springdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07518186A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
- Highlands Oncology Group, PA, Springdale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07477587Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- University of Arkansas for Medical Sciences, Little Rock
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06297226Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04566328A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Highlands Oncology Group - Springdale /ID# 267742, Springdale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05650632Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
- University of Arkansas for Medical Sciences, Little Rock
RecruitingPhase 3
All ages · All sexes · Updated Jun 10, 2026 · NCT05561387Limited-duration Teclistamab
- University of Arkansas for Medical Sciences, Little Rock
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2025 · NCT05932680From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.